Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...

New documents obtained by DeSmog from the papers of John W. Hill, founder of public relations firm Hill & Knowlton, show how ...

We decided to test popular artificial intelligence (AI) chatbots for performing fairly simple and common tasks. For this ...